Alignment Healthcare, Inc.
ALHC- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001832466
In the last 90 days, Alignment Healthcare, Inc. insiders filed 0 open-market purchases and 9 sales; 324 institutions reported holding it in 13F filings for Q2 2026, worth $5.29B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Alignment Healthcare, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 9 filings
- 3 insiders, $23.7M in total
- Insiders trading
- 3
- Net value
- −$23.7M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Alignment Healthcare, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Konowiecki Joseph S | EVP, Corporate Affairs | 1,080,305 | Sep 18, 2026 | 10 |
| Kao John E | Chief Executive Officer | 590,766Indirect | Sep 16, 2026 | 19 |
| Maroney Dawn Christine | President | 794,606 | Sep 11, 2026 | 15 |
| Hochradel Shane J. | Chief Operations Officer | 87,719 | Jul 2, 2026 | 1 |
| Kim Hyong | Chief Medical Officer | 331,750 | Jun 15, 2026 | 6 |
| Kent Mark D. | President - MSO | 102,567 | Jun 9, 2026 | 2 |
| Head James M | Chief Financial Officer | 173,495 | Apr 8, 2026 | 2 |
| Joyce Christopher J | Chief Legal and Admin. Officer | 305,451 | Apr 1, 2026 | 6 |
| Scavo Robert L. | Chief Information Officer | 487,685 | Mar 19, 2026 | 3 |
| Burzacchi Sebastian | COO - Mgmt Services Org | 258,630 | Mar 19, 2026 | 3 |
| Wagner Andreas P. | Chief Human Resources Officer | 148,628 | Mar 19, 2026 | 4 |
| Bilney Jody L | Director | 129,267 | Mar 17, 2026 | 1 |
| Jorden Yon | Director | 105,830 | Mar 17, 2026 | 1 |
| Hodgson David C | Director | 173,408 | Mar 17, 2026 | 1 |
| Kosecoff Jacqueline B | Director | 303,963 | Mar 17, 2026 | 1 |
| McCarthy Margaret M | Director | 144,441 | Mar 17, 2026 | 1 |
| McClellan Mark B. | Director | 370,531 | Mar 17, 2026 | 1 |
| Vorhoff Nicholas Robbert | Director | 173,408 | Mar 17, 2026 | 1 |
| Mansour Adnan R. | Chief Digital Officer | 48,456 | Mar 17, 2026 | 2 |
| General Atlantic, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gapco GmbH & Co KG | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gapco Management GmbH | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gap Coinvestments III, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gap Coinvestments IV, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| GAP Coinvestments CDA, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic Genpar, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic Partners 95, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic (SPV) GP, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| GAP Coinvestments V, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic (ALN HLTH), L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Freeman Robert Thomas | Chief Financial Officer | 1,464,419 | Mar 28, 2025 | 0 |
| Kardes Hakan | Chief Experience Officer | 678,987 | Mar 28, 2025 | 0 |
| Margolis Jeffrey H | Director | 413,533Indirect | Aug 16, 2024 | 0 |
| Carella Thomas J. | Director | 124,478 | Mar 15, 2024 | 0 |
| Kimbro Melinda Michele | Chief People Officer | 175,439 | Jul 7, 2023 | 0 |
| Kumar Dinesh M. | Chief Med & Operating Officer | 1,088,651 | Mar 31, 2023 | 0 |
| Cross Richard A. | SVP, General Counsel | 393,460 | Mar 31, 2023 | 0 |
| Warburg Pincus & Co. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Partners GP LLC | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Partners II Holdings, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus LLC | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| WP Global LLC | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII-B, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII-D, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII-E, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus XII Partners, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| WP XII Partners, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Partners II, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus XII, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
Showing the 50 most recent filers.
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 (view filing) | Oct 13 | 2 days | Kao John EChief Executive Officer | SSaleCommon Stock, par value $0.001 per share ("Common Stock") | −155.6K | $18.44 | −$2.87M | −3.6%4.13M after | |
| Oct 15, 2021 (view filing) | Oct 13-14 | 2 days | Kao John EChief Executive Officer | SSale | −44.4K | $18.83 | −$835.5K | −1.1%4.09M after | 2 lots |
| Oct 15, 2021 (view filing) | Oct 13 | 2 days | Kumar Dinesh M.Chief Medical Officer | SSaleCommon Stock, par value $0.001 per share | −10.0K | $18.08 | −$180.8K | −0.9%1.08M after | |
| Oct 15, 2021 (view filing) | Oct 13 | 2 days | Margolis Jeffrey HDirector | SSaleCommon Stock, par value $0.001 per share ("Common Stock") | −1.20K | $18.00 | −$21.6K | −0.3%427.9K after | |
| Oct 22, 2021 (view filing) | Oct 20 | 2 days | Freeman Robert ThomasChief Financial Officer | SSale | −23.0K | $19.38 | −$445.7K | −2.7%817.2K after | |
| Nov 3, 2021 (view filing) | Nov 1-2 | 2 days | Kao John EChief Executive Officer | SSale | −100.0K | $19.92 | −$1.99M | −2.4%3.99M after | 2 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Kumar Dinesh M.Chief Medical Officer | SSale | −10.0K | $19.87 | −$198.7K | −0.9%1.07M after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Margolis Jeffrey HDirector | SSale | −1.20K | $19.82 | −$23.8K | −0.3%426.7K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Freeman Robert ThomasChief Financial Officer | SSale | −85.3K | $20.11 | −$1.71M | −10.4%731.9K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Furman Donald StevenChief Clinical Officer | SSale | −100.0K | $20.11 | −$2.01M | −5.2%1.83M after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Kao John EChief Executive Officer | SSale | −419.6K | $20.11 | −$8.44M | −10.5%3.57M after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Kumar Dinesh M.Chief Medical Officer | SSale | −83.4K | $20.11 | −$1.68M | −7.8%987.1K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −127.8K | $20.11 | −$2.57M | −7.8%1.51M after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | McClellan Mark B.Director | SSale | −7.50K | $20.11 | −$150.8K | −2.6%276.8K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | General Atlantic (ALN HLTH), L.P.Director, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −6.26M | $20.11 | −$125.9M | −8.2%70.1M after | |
| Nov 24, 2021 (view filing)6:34 PM ET | Nov 23 | 1 day | Warburg Pincus LLC and 9 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.03M | $20.11 | −$40.9M | −8.2%22.8M after | |
| Nov 24, 2021 (view filing)6:34 PM ET | Nov 23 | 1 day | Warburg Pincus & Co. and 2 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.03M | $20.11 | −$40.9M | −8.2%22.8M after | Duplicate filing |
| Nov 24, 2021 (view filing)6:35 PM ET | Nov 23 | 1 day | General Atlantic, L.P. and 9 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −6.26M | $20.11 | −$125.9M | −8.2%70.1M after | |
| Apr 1, 2022 (view filing) | Mar 31 | 1 day | Cross Richard A.SVP, General Counsel | SSale | −1.59K | $11.18 | −$17.8K | −0.5%297.9K after | |
| Apr 1, 2022 (view filing) | Mar 31 | 1 day | Furman Donald StevenChief Clinical Officer | SSale | −3.01K | $11.18 | −$33.6K | −0.2%1.83M after | |
| Apr 1, 2022 (view filing) | Mar 31 | 1 day | Kao John EChief Executive Officer | SSale | −26.4K | $11.18 | −$294.8K | −3.3%781.4K after | |
| Apr 1, 2022 (view filing) | Mar 31 | 1 day | Kumar Dinesh M.Chief Medical Officer | SSale | −3.06K | $11.18 | −$34.2K | −0.3%1.19M after | |
| Apr 1, 2022 (view filing) | Mar 31-Apr 1 | 1 day | Freeman Robert ThomasChief Financial Officer | SSale | −8.24K | $11.28 | −$92.9K | −2.0%412.3K after | 2 lots |
| Apr 1, 2022 (view filing) | Mar 31 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −6.68K | $11.18 | −$74.7K | −0.4%1.71M after | |
| Apr 1, 2022 (view filing) | Mar 31 | 1 day | Shrestha RajeshPres., New Markets & CBO | SSale | −14.2K | $11.18 | −$159.0K | −7.7%170.2K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −13.8K | $11.10 | −$153.0K | −0.8%1.67M after | |
| Jun 17, 2022 (view filing) | Jun 17 | Same day | Freeman Robert ThomasChief Financial Officer | SSale | −12.0K | $11.18 | −$134.2K | −1.6%719.9K after | |
| Jun 17, 2022 (view filing) | Jun 16 | 1 day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −10.0K | $11.04 | −$110.4K | −0.8%1.18M after | |
| Jun 17, 2022 (view filing) | Jun 16 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −2.15K | $10.96 | −$23.6K | −0.1%1.67M after | |
| Jun 23, 2022 (view filing) | Jun 21-22 | 2 days | Freeman Robert ThomasChief Financial Officer | SSale | −3.62K | $12.01 | −$43.4K | −0.5%716.3K after | 2 lots |
| Jun 23, 2022 (view filing) | Jun 21-22 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −3.68K | $12.01 | −$44.2K | −0.3%1.18M after | 2 lots |
| Jul 1, 2022 (view filing) | Jul 1 | Same day | Freeman Robert ThomasChief Financial Officer | SSale | −12.0K | $11.40 | −$136.8K | −1.7%704.3K after | |
| Jul 1, 2022 (view filing) | Jul 1 | Same day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −10.0K | $11.40 | −$114.0K | −0.8%1.17M after | |
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Freeman Robert ThomasChief Financial Officer | SSale | −20.4K | $12.48 | −$254.4K | −2.9%683.9K after | |
| Jul 7, 2022 (view filing) | Jul 5-6 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −36.3K | $12.76 | −$463.3K | −3.1%1.13M after | 2 lots |
| Jul 8, 2022 (view filing) | Jul 6-8 | 2 days | Kao John EChief Executive Officer | SSale | −95.9K | $13.78 | −$1.32M | −2.7%3.47M after | 4 lots |
| Jul 8, 2022 (view filing) | Jul 7-8 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −40.0K | $14.19 | −$567.5K | −2.4%1.63M after | 2 lots |
| Jul 11, 2022 (view filing) | Jul 11 | Same day | Kao John EChief Executive Officer | SSale | −4.11K | $14.08 | −$57.8K | −0.1%3.47M after | |
| Aug 2, 2022 (view filing) | Aug 1-2 | 1 day | Kao John EChief Executive Officer | SSale | −50.0K | $14.60 | −$730.1K | −1.4%3.42M after | 2 lots |
| Aug 2, 2022 (view filing) | Aug 1 | 1 day | Freeman Robert ThomasChief Financial Officer | SSale | −24.0K | $14.50 | −$348.0K | −3.5%659.9K after | |
| Aug 2, 2022 (view filing) | Aug 1 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −20.0K | $14.47 | −$289.4K | −1.2%1.61M after | |
| Aug 2, 2022 (view filing) | Aug 1 | 1 day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −30.0K | $14.49 | −$434.7K | −2.7%1.10M after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | General Atlantic (ALN HLTH), L.P.Director, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.12M | $16.90 | −$35.8M | −3.0%67.9M after | |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Kao John EChief Executive Officer | SSale | −66.2K | $18.57 | −$1.23M | −1.9%3.35M after | 2 lots |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Freeman Robert ThomasChief Financial Officer | SSale | −43.4K | $18.54 | −$805.0K | −6.6%616.5K after | 2 lots |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −44.1K | $18.54 | −$817.6K | −4.0%1.06M after | 2 lots |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Margolis Jeffrey HDirector | SSale | −1.20K | $18.00 | −$21.6K | −0.3%425.5K after | |
| Aug 9, 2022 (view filing)11:44 AM ET | Aug 8 | 1 day | General Atlantic, L.P. and 9 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.12M | $16.90 | −$35.8M | −3.0%67.9M after | Duplicate filing |
| Aug 12, 2022 (view filing) | Aug 11 | 1 day | Kao John EChief Executive Officer | SSale | −500.0K | $15.95 | −$7.97M | −14.9%2.85M after | |
| Aug 16, 2022 (view filing)11:08 AM ET | Aug 9 | 7 daysLate | Warburg Pincus LLC and 9 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.12M | $16.16 | −$34.3M | −9.3%20.6M after |